Compounds > hydralazine

hydralazine and dinoprost

hydralazine has been researched along with dinoprost in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Allen, J; Forman, A; Maigaard, S; Skajaa, K1
Siegl, PK; Wenger, HC1
Fehér, J; Gachályi, B; Juhász, I; Székács, B1
Bates, JN; Hashmi-Hill, MP; Lewis, SJ; Owen, JR; Robertson, TP; Sandock, K1
Hashimoto, T; Hirawa, N; Imai, N; Ishigami, T; Kihara, M; Kitamura, H; Kiuchi, Y; Nomura, K; Tamura, K; Toya, Y; Umemura, S; Yasuzaki, H; Yoshida, S1

Other Studies

7 other study(ies) available for hydralazine and dinoprost

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Effects of vasodilators on isolated human uteroplacental arteries.
    Obstetrics and gynecology, 1991, Volume: 77, Issue:5

    Topics: Angiotensin II; Arteries; Chorionic Villi; Dinoprost; Female; Humans; Hydralazine; Labetalol; Nitrendipine; Norepinephrine; Potassium; Prazosin; Pregnancy; Uterus; Vasoconstriction; Vasodilator Agents; Vasopressins

1991
Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog.
    European journal of pharmacology, 1985, Jul-31, Volume: 113, Issue:3

    Topics: Anesthesia; Animals; Dinoprost; Dogs; Epoprostenol; Female; Hemodynamics; Hydralazine; Male; Nifedipine; Nitroprusside; Prostaglandin D2; Prostaglandins D; Prostaglandins F; Prostaglandins, Synthetic; Stereoisomerism; Vasodilation; Verapamil

1985
TxA2-PGI2-PGF2 alfa responses in the kidney to blood pressure reduction induced by vasodilator/vasorelaxing agents with different action in patients with essential hypertension.
    Acta physiologica Hungarica, 1993, Volume: 81, Issue:4

    Topics: Adolescent; Adult; Blood Pressure; Dinoprost; Epoprostenol; Female; Gallopamil; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Kidney; Male; Middle Aged; Prazosin; Prostaglandins; Sodium; Thromboxane A2; Vasodilator Agents; Venous Pressure

1993
ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Vascular pharmacology, 2006, Volume: 44, Issue:6

    Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Cysteine; Dinoprost; Dose-Response Relationship, Drug; Enalapril; Femoral Artery; Glutathione Disulfide; Hydralazine; Hypertension; Male; Nitric Oxide Donors; Oxidative Stress; Rats; Rats, Inbred SHR; S-Nitrosothiols; Splanchnic Circulation; Vascular Resistance; Vasodilation; Vasodilator Agents

2006
Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy.
    Nephron. Experimental nephrology, 2009, Volume: 111, Issue:1

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Deoxyguanosine; Diabetes Mellitus; Diabetic Nephropathies; Dinoprost; Disease Models, Animal; Hydralazine; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Tetrazoles; Treatment Outcome; Tyrosine

2009